Atlas Trials

Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)

Clinical trial NCT06234345 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06234345
Sponsor
Eurofarma Laboratorios S.A.
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2026-09-01
Primary completion
2028-08-01
Enrollment
1252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.